Results 61 to 70 of about 181,956,994 (291)
Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - JUN 03-07, 2016 - Chicago, IL0000-0002-8253-5046WOS: 000404712500293Amer Soc Clin ...
Güç, Zeynep Gülsüm +6 more
core +1 more source
ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source
Interpretation and Comparison of ESMO Magnitude of Clinical Benefit Scale and ASCO Value Framework
With continuous advances in cancer treatment, clinical oncology therapies have grown increasingly diverse. However, the rapid uptake of these novel therapies has driven up healthcare costs and complicated value assessments.
Yilin FU, Yingying ZHU, Jibin LI
doaj +1 more source
American Society of Clinical Oncology’s Global Oncology Leadership Task Force: Findings and Actions
In response to rising cancer incidence and mortality rates in low- and middle-income countries and the increasingly global profile of ASCO’s membership, the ASCO Board of Directors appointed the Global Oncology Leadership Task Force (Task Force) to ...
Gabriel N. Hortobagyi +11 more
doaj +1 more source
Objective The objective of this study was to evaluate the real‐world effectiveness and safety of secukinumab in patients with giant cell arteritis (GCA). Methods This multicenter retrospective study included patients with GCA who received secukinumab at 14 Italian centers with at least six months of follow‐up.
Luca Iorio +28 more
wiley +1 more source
Immunotherapy has revolutionized cancer treatment, but currently, immuno-oncology agents have not been approved for patients with soft tissue sarcomas.
Matthieu Roulleaux-Dugage +1 more
doaj +1 more source
Mechanoactive Biomaterials for Cell–Matrix Mechanotransduction
The graphical abstract shows how individual triggers (force, light, or temperature) and combined optothermal or receptor‐targeted actuation induce material responses at the tissue, cellular, and receptor scales. Their spatial (global or focused) and temporal (continuous or cyclic) modulation determines the resulting mechanical output.
Yi‐Tung Lu +2 more
wiley +1 more source
Alteration of tumor metabolism after radiotherapy
40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA…Amer Soc Clin ...
M. Cengiz +9 more
core +1 more source
Intelligent Micro/Nanorobots for Targeted Interventional Therapy: From Bench to Clinic
Zirui Zhang et al. reviewed the application and challenges of mobile nanomachines in interventional therapy. By converting exogenous energy, including chemical, magnetic, optical, and ultrasonic sources, into mechanical forces, micro/nanorobots (MNRs) enable precise actuation at unprecedented scales. Evolving far beyond traditional drug delivery, these
Zirui Zhang +5 more
wiley +1 more source
Clinical significance of serum macrophage migration inhibitory factor (MIF) level in breast cancer.
50th Annual Meeting of the American-Society-of-Clinical-Oncology -- MAY 30-JUN 03, 2014 -- Chicago, IL[Abstract Not Available]Amer Soc Clin ...
Tas, Faruk +6 more
core +1 more source

